Everest Medicines Limited
HKEX:1952.HK
22.9 (HKD) • At close September 19, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) HKD.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 58.519 | 58.519 | 4.448 | 4.448 | 5.874 | 5.874 | 0.522 | 0.522 | 0.027 | 0.027 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Kosten van de omzet
| 15.548 | 15.548 | 1.659 | 1.659 | 2.141 | 2.141 | 0.182 | 0.182 | 0.012 | 0.012 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Brutowinst
| 42.971 | 42.971 | 2.789 | 2.789 | 3.734 | 3.734 | 0.34 | 0.34 | 0.016 | 0.016 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Brutowinstmarge
| 0.734 | 0.734 | 0.627 | 0.627 | 0.636 | 0.636 | 0.651 | 0.651 | 0.574 | 0.574 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Onderzoek- en ontwikkelingskosten
| 125.783 | 125.783 | 144.244 | 144.244 | 232.112 | 232.112 | 172.756 | 172.756 | 181.33 | 181.33 | 125.387 | 125.387 | 108.193 | 108.193 | 80.841 | 80.184 | 22.808 |
| Algemene en administratieve kosten
| 40.732 | 40.732 | 41.233 | 41.233 | 78.463 | 78.463 | 59.173 | 59.173 | 66.914 | 66.914 | 52.342 | 52.342 | 88.045 | 88.045 | 78.614 | 22.702 | 3.645 |
| Verkoop- en marketingkosten
| 83.646 | 83.646 | 32.064 | 32.064 | 89.264 | 89.264 | 74.08 | 74.08 | 78.026 | 78.026 | 21.049 | 21.049 | 12.043 | 12.043 | 6.36 | 2.8 | 0 |
| Verkoop-, algemene en administratieve kosten
| 124.657 | 124.657 | 73.631 | 73.631 | 168.083 | 168.083 | 133.535 | 133.535 | 145.65 | 145.65 | 74.763 | 74.763 | 100.302 | 100.302 | 84.974 | 25.502 | 3.645 |
| Overige kosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -46.163 | 45.22 | 3.412 |
| Bedrijfskosten
| 271.103 | 271.103 | 239.192 | 239.192 | 195.674 | 195.674 | 339.828 | 339.828 | 327.263 | 327.263 | 189.15 | 189.15 | 2,510.142 | 2,510.142 | 119.652 | 150.906 | 29.865 |
| Bedrijfsresultaat
| -211.736 | -211.736 | -213.898 | -213.898 | -396.922 | -396.922 | -305.431 | -305.431 | -325.517 | -325.517 | -199.119 | -199.119 | -208.426 | -208.426 | -119.763 | 304.589 | 99.532 |
| Bedrijfsresultaat ratio
| -3.618 | -3.618 | -48.094 | -48.094 | -67.573 | -67.573 | -585.117 | -585.117 | -12,056.185 | -12,056.185 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Totaal overige inkomsten en kosten netto
| 1.31 | 1.31 | 2.092 | 2.092 | 607.305 | 607.305 | -28.59 | -28.59 | 12.712 | 12.712 | 7.565 | 7.565 | -2,308.892 | -2,308.892 | -807.727 | -0.63 | -0.409 |
| Inkomen voor belasting
| -210.426 | -210.426 | -211.806 | -211.806 | 210.384 | 210.384 | -334.021 | -334.021 | -312.806 | -312.806 | -191.554 | -191.554 | -2,517.317 | -2,517.317 | -927.49 | 303.959 | 99.123 |
| Inkomen voor belasting ratio
| -3.596 | -3.596 | -47.624 | -47.624 | 35.816 | 35.816 | -639.887 | -639.887 | -11,585.389 | -11,585.389 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Belastingkosten
| 0 | 0 | -0 | 0 | 0.004 | 0.004 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.071 | 0.63 | 0.409 |
| Nettowinst
| -210.426 | -210.426 | -211.806 | -211.806 | 210.38 | 210.38 | -334.021 | -334.021 | -312.806 | -312.806 | -191.554 | -191.554 | -2,517.317 | -2,517.317 | -934.561 | 303.959 | 99.123 |
| Nettowinstmarge
| -3.596 | -3.596 | -47.624 | -47.624 | 35.815 | 35.815 | -639.887 | -639.887 | -11,585.389 | -11,585.389 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| WPA (Winst Per Aandeel)
| -0.65 | -0.65 | -0.7 | -0.7 | 0.7 | 0.7 | -1.13 | -1.13 | -1.07 | -1.07 | -0.65 | -0.65 | -17.26 | -17.26 | -3.29 | 1.07 | 0.35 |
| Verwaterde WPA
| -0.65 | -0.65 | -0.7 | -0.7 | 0.7 | 0.7 | -1.13 | -1.13 | -1.07 | -1.07 | -0.65 | -0.65 | -17.26 | -17.26 | -3.29 | 1.07 | 0.35 |
| EBITDA
| -198.785 | -198.785 | -203.637 | -203.637 | -393.404 | -393.404 | -302.043 | -302.043 | -323.851 | -323.851 | -197.681 | -197.681 | -207.253 | -207.253 | -913.715 | 307.773 | 101.321 |
| EBITDA ratio
| -3.397 | -3.397 | -45.787 | -45.787 | -66.974 | -66.974 | -578.626 | -578.626 | -11,994.463 | -11,994.463 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |